Skip to main content
. Author manuscript; available in PMC: 2015 May 7.
Published in final edited form as: Radiology. 2008 Mar 27;247(2):391–399. doi: 10.1148/radiol.2472070363

Figure 3.

Figure 3

Graph shows tumor volume ratios (tumor volume at day x [Vx] divided by baseline pretreatment tumor volume ([V0]) given as mean values ± standard errors of the mean (error bars) in control (saline-treated) and bevacizumab-treated tumors over 11 days. Curved lines represent monoexponenial best fits. The tumor volume ratio was significantly higher (P < .05) at the completion of tumor treatment (11 days) in the control, uninhibited, saline-treated tumors than in the bevacizumab-treated, angiogenically inhibited tumors.